NZ506115A - Contraceptive kit containing a compound with both estrogenic and progestagenic activity - Google Patents

Contraceptive kit containing a compound with both estrogenic and progestagenic activity

Info

Publication number
NZ506115A
NZ506115A NZ506115A NZ50611599A NZ506115A NZ 506115 A NZ506115 A NZ 506115A NZ 506115 A NZ506115 A NZ 506115A NZ 50611599 A NZ50611599 A NZ 50611599A NZ 506115 A NZ506115 A NZ 506115A
Authority
NZ
New Zealand
Prior art keywords
contraceptive
compound
formula
steroid compound
steroid
Prior art date
Application number
NZ506115A
Other languages
English (en)
Inventor
Helenius Jan Kloosterboer
Godefridus Hermanus Jo Deckers
Johannes Antonius Mar Hamersma
Bennink Herman Jan Ti Coelingh
Pieter Michiel Verbost
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NZ506115A publication Critical patent/NZ506115A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NZ506115A 1998-03-09 1999-03-03 Contraceptive kit containing a compound with both estrogenic and progestagenic activity NZ506115A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09
PCT/EP1999/001404 WO1999045886A2 (fr) 1998-03-09 1999-03-03 Nouveau kit de contraception

Publications (1)

Publication Number Publication Date
NZ506115A true NZ506115A (en) 2003-07-25

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ506115A NZ506115A (en) 1998-03-09 1999-03-03 Contraceptive kit containing a compound with both estrogenic and progestagenic activity

Country Status (20)

Country Link
EP (1) EP1061928A2 (fr)
JP (1) JP2002506014A (fr)
KR (1) KR20010041698A (fr)
CN (1) CN1292702A (fr)
AR (1) AR018313A1 (fr)
AU (1) AU756882B2 (fr)
BR (1) BR9908605A (fr)
CA (1) CA2319765A1 (fr)
CO (1) CO5070598A1 (fr)
HU (1) HUP0101007A3 (fr)
ID (1) ID25621A (fr)
IL (1) IL137541A0 (fr)
NO (1) NO20004492D0 (fr)
NZ (1) NZ506115A (fr)
PE (1) PE20000330A1 (fr)
PL (1) PL343428A1 (fr)
RU (1) RU2225714C2 (fr)
TR (1) TR200002593T2 (fr)
WO (1) WO1999045886A2 (fr)
ZA (1) ZA991851B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (fr) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Kit contraceptif base uniquement sur la progestogene
PL353826A1 (en) * 1999-09-06 2003-12-01 Akzo Nobel N.V.Akzo Nobel N.V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
SK882003A3 (en) 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
JP2005519964A (ja) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファターゼ阻害プロゲストゲンのみの避妊レジメン
WO2003077925A1 (fr) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Regime contraceptif continu a base de progestogene inhibiteur de la sulfatase
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
HUP0101007A3 (en) 2002-02-28
BR9908605A (pt) 2001-04-24
AU756882B2 (en) 2003-01-23
RU2225714C2 (ru) 2004-03-20
CO5070598A1 (es) 2001-08-28
IL137541A0 (en) 2001-07-24
JP2002506014A (ja) 2002-02-26
ID25621A (id) 2000-10-19
AR018313A1 (es) 2001-11-14
CA2319765A1 (fr) 1999-09-16
ZA991851B (en) 1999-09-22
PL343428A1 (en) 2001-08-13
CN1292702A (zh) 2001-04-25
AU3143799A (en) 1999-09-27
NO20004492L (no) 2000-09-08
KR20010041698A (ko) 2001-05-25
HUP0101007A2 (hu) 2001-12-28
NO20004492D0 (no) 2000-09-08
EP1061928A2 (fr) 2000-12-27
WO1999045886A2 (fr) 1999-09-16
WO1999045886A3 (fr) 1999-12-02
PE20000330A1 (es) 2000-05-16
TR200002593T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
US5439913A (en) Contraception method using competitive progesterone antagonists and novel compounds useful therein
JP4023820B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体を含有する医薬製剤
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
WO2013064620A1 (fr) 18-méthyl-6,7-méthylène-3-oxo-17-prégn-4-ène-21,17β-carbolactones, préparations pharmaceutiques contenant ces composés et leur utilisation dans le traitement de l'endométriose
JP2000502108A (ja) ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット
AU756882B2 (en) New contraceptive kit
CZ290690B6 (cs) Léčivo pro podle potřeby zaměřenou kontrolu samičí fertility
CA2309745A1 (fr) Regime progestatif-antiprogestatif
MXPA00008814A (en) New contraceptive kit
WO1999051214A2 (fr) Kit contraceptif base uniquement sur la progestogene
CZ20003285A3 (cs) Antikoncepční sada
US3816406A (en) O-aryl oximes of 3-keto steroids
CZ20013874A3 (cs) Farmaceutický prostředek
EP2773356A1 (fr) 18-méthyl-6,7-méthylène-3-oxo-17-prégn-4-ène-21,17 -carbolactones, préparations pharmaceutiques contenant ces composés et leur utilisation dans le traitement de l'endométriose

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)